Prescription drug · NDA
Depo-Medrol (methylprednisolone acetate) NDC 50090-2098
Methylprednisolone acetate 40 mg/mL · Injection, Suspension · Intra-articular, Intralesional, Intramuscular, Soft tissue · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-2098-0 | 50090209800 | 1 VIAL, SINGLE-DOSE in 1 PACKAGE (50090-2098-0) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Oct 13, 2015 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Depo-Medrol
- Generic name (nonproprietary)
- methylprednisolone acetate
- Active ingredients
- Methylprednisolone acetate — 40 mg/mL
- Dosage form
- Injection, Suspension
- Route
- Intra-articular, Intralesional, Intramuscular, Soft tissue
- Labeler
- A-S Medication Solutions
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 011757
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 50090-2098_3cb9b45d-cbb7-4812-a239-ba572781666bSPL ID 3cb9b45d-cbb7-4812-a239-ba572781666bSPL set ID cb457bef-8823-4f3c-987b-eb0922494c46RxCUI 1743779, 1743781UNII 43502P7F0P
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeMed-Code curated
J1040 — Injection, methylprednisolone acetate, 80 mg
Billing unit: 80 mg. Units on the claim = dose given ÷ 80 mg.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N450090209800followed by a unit qualifier and the quantityPackage 50090-2098-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE A. For Intramuscular Administration When oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intramuscular use of DEPO-MEDROL Sterile Aqueous Suspension is indicated as follows: Allergic States : Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic Diseases : Bullous dermatitis herpetiformis, exfoliative dermatitis, mycosis fungoides, pemphigus, severe erythema …
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 011757
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Depo-Medrolmethylprednisolone acetate | Methylprednisolone acetate 40 mg/mL | Injection, SuspensionIntralesional, Intramuscular, Intrasynovial, Soft tissue | Pharmacia & Upjohn Company LLC | 0009-3073 |
| Depo-Medrolmethylprednisolone acetate | Methylprednisolone acetate 20 mg/mL | Injection, SuspensionIntralesional, Intramuscular, Intrasynovial, Soft tissue | Pharmacia & Upjohn Company LLC | 0009-0274 |
| Depo-Medrolmethylprednisolone acetate | Methylprednisolone acetate 40 mg/mL | Injection, SuspensionIntralesional, Intramuscular, Intrasynovial, Soft tissue | A-S Medication Solutions | 50090-0556 |
| Depo-Medrolmethylprednisolone acetate | Methylprednisolone acetate 80 mg/mL | Injection, SuspensionIntralesional, Intramuscular, Intrasynovial, Soft tissue | A-S Medication Solutions | 50090-1823 |
| Depo-Medrolmethylprednisolone acetate | Methylprednisolone acetate 80 mg/mL | Injection, SuspensionIntralesional, Intramuscular, Intrasynovial, Soft tissue | Pharmacia & Upjohn Company LLC | 0009-0306 |
| Depo-Medrolmethylprednisolone acetate | Methylprednisolone acetate 40 mg/mL | Injection, SuspensionIntralesional, Intramuscular, Intrasynovial, Soft tissue | Pharmacia & Upjohn Company LLC | 0009-0280 |
| Depo-Medrolmethylprednisolone acetate | Methylprednisolone acetate 40 mg/mL | Injection, SuspensionIntra-articular, Intralesional, Intramuscular, Soft tissue | Pharmacia & Upjohn Company LLC | 0009-3073 |
| Depo-Medrolmethylprednisolone acetate | Methylprednisolone acetate 80 mg/mL | Injection, SuspensionIntra-articular, Intralesional, Intramuscular, Soft tissue | Pharmacia & Upjohn Company LLC | 0009-3475 |
| Depo-Medrolmethylprednisolone acetate | Methylprednisolone acetate 80 mg/mL | Injection, SuspensionIntra-articular, Intralesional, Intramuscular, Soft tissue | Asclemed USA, Inc. | 76420-081 |
| Depo-Medrolmethylprednisolone acetate | Methylprednisolone acetate 80 mg/mL | Injection, SuspensionIntra-articular, Intralesional, Intramuscular, Soft tissue | A-S Medication Solutions | 50090-0436 |